Rankings
▼
Calendar
LXRX Q1 2024 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+4608.3% YoY
Gross Profit
$955,000
84.5% margin
Operating Income
-$45M
-4011.8% margin
Net Income
-$48M
-4282.9% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
+61.0%
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$55M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$417M
Total Liabilities
$128M
Stockholders' Equity
$289M
Cash & Equivalents
$96M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$24,000
+4608.3%
Gross Profit
$955,000
$24,000
+3879.2%
Operating Income
-$45M
-$31M
-45.6%
Net Income
-$48M
-$32M
-51.6%
← FY 2024
All Quarters
Q2 2024 →